Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M15,485Revenue (TTM) $M1,117Net Margin (%)-56.4Altman Z-Score6.6
Enterprise Value $M15,379EPS (TTM) $-3.8Operating Margin %-71.9Piotroski F-Score3
P/E(ttm)--Beneish M-Score-2.8Pre-tax Margin (%)-74.4Higher ROA y-yN
Price/Book5.510-y EBITDA Growth Rate %--Quick Ratio2.4Cash flow > EarningsY
Price/Sales13.25-y EBITDA Growth Rate %182Current Ratio3.2Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-17.2Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-26.2Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M173ROIC % (ttm)-25.4Gross Margin Increase y-yN

Gurus Latest Trades with BMRN

Number of guru portfolios checked: 69.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

BMRN is held by these investors:



BMRN: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Davis George EricEVP, General Counsel 2017-03-16Sell2,238$91.96-2.51view
SPIEGELMAN DANIEL KEVP, CFO 2017-03-16Sell1,989$91.96-2.51view
BIENAIME JEAN JACQUESCEO 2017-03-16Sell10,000$91.69-2.22view
BIENAIME JEAN JACQUESCEO 2017-03-13Sell5,000$92.68-3.27view
BIENAIME JEAN JACQUESCEO 2017-03-10Sell11,000$90.59-1.04view
Ajer Jeffrey RobertEVP, Chief Commercial Officer 2017-03-07Sell5,000$90.56-1view
SPIEGELMAN DANIEL KEVP, CFO 2017-03-06Sell2,303$93.32-3.93view
Davis George EricEVP, General Counsel 2017-03-06Sell1,498$93.32-3.93view
SPIEGELMAN DANIEL KEVP, CFO 2017-03-01Sell35,000$94.07-4.7view
LAWLIS V BRYANDirector 2017-03-01Sell7,500$95-5.63view

Press Releases about BMRN :

Quarterly/Annual Reports about BMRN:

News about BMRN:

Articles On GuruFocus.com
Piotroski F-Score in the Real World Dec 19 2016 
U.S. Elections: What They Might Mean for Investors - JOHCM Commentary Nov 29 2016 
Low Valuation Ratios Lead to Strong Portfolio Returns Sep 13 2016 
Sam Isaly Swaps 3 Health Care Stocks in Second Quarter Jul 29 2016 
Roche Holdings Definitely Not a Lumbering Giant Jul 11 2016 
Spiros Segalas Buys McDonald's, Microsoft, Alibaba May 05 2016 
Kyle Bass Sells Stakes in 11 Health Care Companies Mar 01 2016 
J.P. Morgan’s 3 Biotechnology Picks Apr 14 2015 
You Can No Longer Ignore Biotech Feb 07 2014 
Weekly Top Insider Sells: AAPL, GILD, BMRN, and PCLN Nov 19 2012 

More From Other Websites
Why Is BioMarin (BMRN) Down 2.2% Since the Last Earnings Report? Mar 28 2017
Catalyst Pharma (CPRX) Focused on U.S. Approval for Firdapse Mar 23 2017
Catalyst Pharmaceuticals Inc (CPRX): Here’s What’s Next Mar 16 2017
BIOMARIN PHARMACEUTICAL INC Financials Mar 02 2017
Coverage initiated on BioMarin Pharm by Instinet Mar 02 2017
Biotechs Leap On Trump's Calls For Innovation, Speedy FDA Approval Mar 01 2017
Biotech Stock Roundup: Kite Soars on CAR-T Data, EXEL in Immuno-Oncology Deals Mar 01 2017
BioMarin Pharmaceutical, Inc. :BMRN-US: Earnings Analysis: 2016 By the Numbers : February 28, 2017 Feb 28 2017
BioMarin Pharmaceutical, Inc. :BMRN-US: Earnings Analysis: Q4, 2016 By the Numbers : February 27,... Feb 27 2017
Blog Coverage Cempra Announced Positive Results from the Phase-III Study for the Treatment of Acute... Feb 27 2017
BIOMARIN PHARMACEUTICAL INC Files SEC form 10-K, Annual Report Feb 27 2017
BioMarin 'Attractive' M&A Target Despite Growing Losses: RBC Feb 24 2017
BioMarin (BMRN) Q4 Loss Narrower than Expected; Sales Beat Feb 24 2017
Edited Transcript of BMRN earnings conference call or presentation 23-Feb-17 9:30pm GMT Feb 24 2017
BioMarin reports 4Q loss Feb 23 2017
BioMarin reports 4Q loss Feb 23 2017
BIOMARIN PHARMACEUTICAL INC Files SEC form 8-K, Results of Operations and Financial Condition,... Feb 23 2017
BioMarin Announces Fourth Quarter and Full Year 2016 Financial Results Feb 23 2017
Q4 2016 Biomarin Pharmaceutical Inc Earnings Release - Time Not Supplied Feb 23 2017

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)